文献速递衰弱、肌少症与跌倒

肾移植后衰弱及其组分的长期轨迹

Long-Term Trajectories of Frailty and Its Components After Kidney Transplantation.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2022-01-01

移植后前2.5年衰弱可能性下降(aOR=0.96,95%CI:0.95,0.98),2.5年后反而上升(aOR=1.03,95%CI:1.00,1.05)。前2.5年体重、握力和活动量增加,2.5年后握力和活动量下降而步速持续缓慢。

要点

  • 移植后前2.5年衰弱改善,体重、握力、活动量增加。
  • 移植2.5年后衰弱可能性上升,握力和活动量下降。
  • 步速在移植后各阶段均保持稳定,持续缓慢。

核心结论

  • 肾移植后衰弱在前2.5年改善,但2.5年后出现恶化,临床应关注2.5年后的衰弱监测。

研究设计与样本

  • 在入院、术后1、3、6个月、1年及之后每年测量PFP组分,采用校正混合效应模型和广义估计方程分析。

主要发现

  • 移植后前2.5年衰弱可能性下降(aOR=0.96,95%CI:0.95,0.98),2.5年后上升(aOR=1.03,95%CI:1.00,1.05)。
  • 前2.5年体重增加0.4 lbs/月(95%CI:0.3,0.5),握力增加0.2 kg/月(95%CI:0.1,0.2),活动量增加23.9 kcal/月(95%CI:17.5,30.2)。
  • 前2.5年步速保持稳定(-0.01 s/月,95%CI:0.01,0.003),疲惫可能性下降(OR=0.99,95%CI:0.98,1.00)。
  • 2.5年后握力下降(-0.07 kg/月,95%CI:-0.12,-0.01),活动量下降(-20 kcal/月,95%CI:-32.3,-8.2)。
  • 2.5年后体重(-0.003 lbs/月,95%CI:-0.17,0.16)、步速(-0.003 s/月,95%CI:-0.02,0.01)和疲惫可能性(OR=1.01,95%CI:0.99,1.02)保持稳定。

关键数值与推荐

  • 衰弱可能性:前2.5年aOR=0.96(95%CI:0.95,0.98),2.5年后aOR=1.03(95%CI:1.00,1.05)。
  • 体重变化:前2.5年0.4 lbs/月(95%CI:0.3,0.5),2.5年后-0.003 lbs/月(95%CI:-0.17,0.16)。
  • 握力变化:前2.5年0.2 kg/月(95%CI:0.1,0.2),2.5年后-0.07 kg/月(95%CI:-0.12,-0.01)。
  • 活动量变化:前2.5年23.9 kcal/月(95%CI:17.5,30.2),2.5年后-20 kcal/月(95%CI:-32.3,-8.2)。
  • 步速变化:前2.5年-0.01 s/月(95%CI:0.01,0.003),2.5年后-0.003 s/月(95%CI:-0.02,0.01)。

临床怎么用

  • 对肾移植受者应长期监测衰弱,尤其移植2.5年后仍可能出现衰弱恶化。
  • 关注移植2.5年后握力和活动量下降,及时评估并干预。
  • 不能因移植后短期衰弱改善而放松长期随访。

局限性

  • 仅两中心数据,外推性有限。
  • 中位随访1.9年,长期数据仍有限。
  • 为观察性研究,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Frailty is common and associated with poor outcomes among kidney transplant (KT) recipients. While frailty improves in the first 3 months post-KT with restored kidney function, longer-term trajectories are likely to plateau/decline due to aging and other stressors (eg, immunosuppression). We evaluated longer-term post-KT trajectories of the physical frailty phenotype (PFP) and its components in adult patients at 2 centers. METHODS: PFP components were measured at admission, 1, 3, 6 months, 1 year, and annually thereafter post-KT. We used adjusted mixed-effects models to describe repeated measures of continuous components (weight, gait speed, grip strength, activity) and generalized estimating equations to quantify longitudinal, binomial response patterns (PFP; exhaustion). RESULTS: Among 1 336 recipients (mean age = 53) followed for a median of 1.9 years (interquartile range [IQR] = 0.1-3.2), likelihood of frailty declined in the first 2.5 years post-KT (adjusted odds ratio [aOR] = 0.96, 95% confidence interval [CI]: 0.95, 0.98), but increased after 2.5 years post-KT (aOR = 1.03, 95% CI: 1.00, 1.05). In the first 2.5 years post-KT, recipients demonstrated increases in weight (0.4 lbs/month, 95% CI: 0.3, 0.5), grip strength (0.2 kg/month, 95% CI: 0.1, 0.2), and activity (23.9 kcal/month, 95% CI: 17.5, 30.2); gait speed remained stable (-0.01 s/month, 95% CI: 0.01, 0.003). Additionally, likelihood of becoming exhausted declined post-KT (OR = 0.99, 95% CI: 0.98, 1.00). After 2.5 years post-KT, recipients demonstrated decreased grip strength (-0.07 kg/month, 95% CI: -0.12, -0.01) and activity (-20 kcal/month, 95% CI: -32.3, -8.2); they had stable weight (-0.003 lbs/month, 95% CI: -0.17, 0.16), gait speed (-0.003 s/month, 95% CI: -0.02, 0.01), and likelihood of becoming exhausted (OR = 1.01, 95% CI: 0.99, 1.02). CONCLUSION: Despite frailty improvements in the first 2.5 years, recipients' frailty worsened after 2.5 years post-KT. Specifically, they experienced gains in strength, activity, and exhaustion in the first 2.5 years post-KT, but declined in strength and activity after 2.5 years post-KT while experiencing persistent slowness. Clinicians should consider monitoring recipients for worsening frailty after 2.5 years despite shorter-term improvements.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Chu NM, Ruck J, Chen X, et al. Long-Term Trajectories of Frailty and Its Components After Kidney Transplantation. J Gerontol A Biol Sci Med Sci. 2022. PMID: 35184167. doi:10.1093/gerona/glac051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。